Adipocyte-specific reduction of phosphodiesterase 3B gene expression and its restoration by JTT-501 in the obese, diabetic KKAy mouse

European Journal of Endocrinology

Volumn 145, Issue 1, 2001, Pages 93-99

  Tang, Y ^a   Osawa, H ^a   Onuma, H ^a   Hasegawa, M ^a   Nishimiya, T ^a   Ochi, M ^a   Makino, H ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; MEMBRANE ENZYME; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PHOSPHODIESTERASE; REGLITAZAR; RIBONUCLEASE; TRIACYLGLYCEROL;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RIBONUCLEASE PROTECTION ASSAY; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING;

EID: 0034912372     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450093     Document Type: Article

References (39)

1. Cyclic nucleotide phosphodiesterases: Relating structure and function
2. The role of insulin-sensitive phosphodiesterase in insulin action
3. Mechanisms regulating adipocyte lipolysis
4. Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases
5. Diabetes mellitus
6. The role of cyclic AMP in rapid and long-term regulation of gluconeogenesis and glycolysis
7. Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis
8. Combined effects of insulin and dexamethasone on cyclic AMP phosphodiesterase 3 and glycogen metabolism in cultured rat hepatocytes
9. Cloning and expression of mouse fatty acid synthase and other specific mRNAs. Developmental and hormonal regulation in 3T3-L1 cells
10. Glucagon and N6,O2′-dibutyryl adenosine 3′:5′-monophosphate inhibition of lipogenesis and phosphofructokinase activity of hepatocytes from meal-fed rats
11. Pathogenesis of NIDDM. A balanced overview
12. What if Minkowski had been ageusic? An alternative angle on diabetes
13. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
14. Insulin resistance of fat cells from spontaneously diabetic KK mice. Analysis of insulin-sensitive phosphodiesterase
15. Effects of changes in serum insulin in response to dexamethasone and adrenalectomy on insulin-sensitive phosphodiesterase in rat fat cells
16. Insulin-sensitive phosphodiesterase and insulin receptor binding in fat cells from spontaneously obese rats
17. Phosphodiesterase activity in human subcutaneous adipose tissue in insulin- and noninsulin-dependent diabetes mellitus
18. Effect of insulin and lipolytic hormones on cyclic AMP phosphodiesterase activity in normal and diabetic rat adipose tissue
19. Cyclic nucleotide phosphodiesterase 3 expression in vivo: Evidence for tissue-specific expression of phosphodiesterase 3A or 3B mRNA and activity in the aorta and adipose tissue of atherosclerosis-prone insulin-resistant rats
20. Improvement in insulin resistance and the restoration of reduced phosphodiesterase 3B gene expression by pioglitazone in adipose tissue of obese diabetic KKAy mice
21. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative
22. Role of JTT-501, a new insulin sensitiser, in restoring impaired GLUT4 translocation in adipocytes of rats fed a high fat diet
23. The Upjohn colony of KKAy mice: A model for obese type II diabetes
24. Metabolism of isolated fat cells
25. Characterization of insulin-sensitive phosphodiesterase in fat cells. I. Effects of salts and oxidation-reduction agents
26. Mitogen-activated protein kinase and p70 ribosomal protein S6 kinase are not involved in the insulin-dependent stimulation of cAMP phosphodiesterase kinase in rat adipocytes
27. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
28. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats
29. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat
30. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase
31. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
32. Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat
33. Adipocyte blood flow: Influence of age, anatomic location, and dietary manipulation
34. Effect of diet on fat cell size and hormone-sensitive lipase activity
35. Relationship between the tissue level of cyclic AMP and the fat cell size of human adipose tissue
36. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue
37. Effect of insulin on glycerol production in obese adolescents
38. Characterization of new oral antidiabetic agent CS-Studies in KK and ob/ob mice and Zucker fatty rats
39. Phosphodiesterase 3B gene expression is enhanced in the liver but reduced in the adipose tissue of obese insulin resistant db/db mouse